199 related articles for article (PubMed ID: 23494989)
1. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia.
Gupta SK; De Becker I; Guernsey DL; Neumann PE
Am J Ophthalmol; 1998 May; 125(5):687-92. PubMed ID: 9625553
[TBL] [Abstract][Full Text] [Related]
3. Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion.
van Heyningen V; Hoovers JM; de Kraker J; Crolla JA
J Med Genet; 2007 Dec; 44(12):787-90. PubMed ID: 17630404
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene.
Drechsler M; Meijers-Heijboer EJ; Schneider S; Schurich B; Grond-Ginsbach C; Tariverdian G; Kantner G; Blankenagel A; Kaps D; Schroeder-Kurth T
Hum Genet; 1994 Oct; 94(4):331-8. PubMed ID: 7927324
[TBL] [Abstract][Full Text] [Related]
5. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
[TBL] [Abstract][Full Text] [Related]
6. Prediction by FISH analysis of the occurrence of Wilms tumor in aniridia patients.
Muto R; Yamamori S; Ohashi H; Osawa M
Am J Med Genet; 2002 Apr; 108(4):285-9. PubMed ID: 11920832
[TBL] [Abstract][Full Text] [Related]
7. Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia.
Crolla JA; van Heyningen V
Am J Hum Genet; 2002 Nov; 71(5):1138-49. PubMed ID: 12386836
[TBL] [Abstract][Full Text] [Related]
8. Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor.
Nakadate H; Tsuchiya T; Maseki N; Hatae Y; Tsunematsu Y; Horikoshi Y; Ishida Y; Kikuta A; Eguchi H; Endo M; Miyake M; Sakurai M; Kaneko Y
Genes Chromosomes Cancer; 1999 May; 25(1):26-32. PubMed ID: 10221336
[TBL] [Abstract][Full Text] [Related]
9. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia.
Grønskov K; Olsen JH; Sand A; Pedersen W; Carlsen N; Bak Jylling AM; Lyngbye T; Brøndum-Nielsen K; Rosenberg T
Hum Genet; 2001 Jul; 109(1):11-8. PubMed ID: 11479730
[TBL] [Abstract][Full Text] [Related]
10. The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
Pritchard-Jones K; Renshaw J; King-Underwood L
Hum Mol Genet; 1994 Sep; 3(9):1633-7. PubMed ID: 7833922
[TBL] [Abstract][Full Text] [Related]
11. [WAGR syndrome by heterozygous deletion of the WT1 gene. Pediatric case report].
Galvis-Blanco SJ; Arias-Flórez JS; Contreras-García GA
Arch Argent Pediatr; 2019 Oct; 117(5):e505-e508. PubMed ID: 31560501
[TBL] [Abstract][Full Text] [Related]
12. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
13. Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization.
Fantes JA; Bickmore WA; Fletcher JM; Ballesta F; Hanson IM; van Heyningen V
Am J Hum Genet; 1992 Dec; 51(6):1286-94. PubMed ID: 1334370
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
15. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetics and molecular genetics of Wilms' tumor of childhood.
Slater RM; Mannens MM
Cancer Genet Cytogenet; 1992 Jul; 61(2):111-21. PubMed ID: 1322233
[TBL] [Abstract][Full Text] [Related]
17. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
[TBL] [Abstract][Full Text] [Related]
18. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
19. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
20. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
Tsuchida Y; Yokomori K; Choi SH
Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
